Alibaba Group Holding has agreed to pay $600 million to resolve allegations with the U.S. government related to illegal sales and imports of pharmaceuticals and regulated chemicals. The settlement covers activity on Alibaba platforms from 2016 to 2024 and closes a multi-year dispute with U.S. authorities. The agreement highlights compliance risks and potential changes to Alibaba's cross-border operations and U.S. exposure. The stock has faced pressure, with shares at $97.99 and declines of 21.9% over the past 30 days and 37.1% year to date.
Alibaba Group Holding LtdAlibaba agrees to $600M settlement over illegal chemical sales, highlighting compliance risks and potential changes to cross-border operations.